Combination therapy is a new standard for treatment of pulmonary arterial hypertension
At present, compelling evidence has been obtained that combined therapy of pulmonary arterial hypertension (PAH) with specific drugs can significantly slow progression of PAH. Therefore, in current guidelines combination therapy is already considered as standard treatment for a significant proportio...
Main Authors: | S N Avdeev, N A Tsareva, I R Gaisin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2018-03-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32752/pdf |
Similar Items
-
Risk stratification methods and their significance in pulmonary arterial hypertension
by: S N Avdeev, et al.
Published: (2019-09-01) -
Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia
by: A. A. Shmalts, et al.
Published: (2020-12-01) -
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?
by: N A Tsareva, et al.
Published: (2017-09-01) -
Evolution of pathogenetic therapy of pulmonary arterial hypertension
by: I E Chazova, et al.
Published: (2019-12-01) -
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults
by: A A Shmalts, et al.
Published: (2019-12-01)